Cargando…
The Biosafety and Risk Management in Preparation and Processing of Cerebrospinal Fluid and Other Neurological Specimens With Potential Coronavirus Infection
The recent outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2, has become a global threat. Due to neurological manifestations presented throughout the coronavirus disease process, the potential involvement of COVID-19 in central nervous system...
Autores principales: | Chen, Chien-Chin, Chiang, Pei-Chun, Chen, Tsung-Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855587/ https://www.ncbi.nlm.nih.gov/pubmed/33551970 http://dx.doi.org/10.3389/fneur.2020.613552 |
Ejemplares similares
-
Identification of protein biomarkers in host cerebrospinal fluid for differential diagnosis of tuberculous meningitis and other meningitis
por: Huang, Mailing, et al.
Publicado: (2022) -
Cerebrospinal Fluid Hypovolemia and Posterior Reversible Encephalopathy Syndrome
por: Zheng, Yuan-yuan, et al.
Publicado: (2020) -
Increased Cerebrospinal Fluid Uric Acid Levels in Guillain–Barré Syndrome
por: Chang, Sheng-Hui, et al.
Publicado: (2020) -
Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Neurocysticercosis
por: Fan, Siyuan, et al.
Publicado: (2018) -
Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
por: Bönig, Lena, et al.
Publicado: (2019)